首頁 > 市場調查報告書 > 生物科技 > 生物科技市場調査評論：2011年

聯絡我們?

市場調查報告書

生物科技市場調査評論：2011年

2011 Biotechnology Research Review

出版商	BCC Research
出版日期	2012年01月	商品編碼	224399
內容資訊	英文 191 Pages
價格	US $ 850 PDF by E-mail (Single User License) US $ 1000 PDF by E-mail (Business Unit License) US $ 1400 PDF by E-mail (Enterprise License)

簡介
目錄
相關商品

生物科技市場調査評論：2011年 是由出版商BCC Research在2012年01月所出版的。這份英文市場調查報告書包含191 Pages 價格從美金850起跳。

簡介

本報告書以今後被認為會大幅發展的生物科技產業為焦點、BCC Research在2011年報告書所提到的聚合酶連鎖反應（PCR）技術、生物銀行、生物晶片、微陣列＆晶片中實驗室的癌症診斷、RNAi藥物輸送、幹細胞腫瘤治療、流式細胞儀、以及基因組學、蛋白質組學、上層表觀基因組學研究用樣本調製技法領域的科學研究、用途開發以及市場等的動向之重新審視、更明確把握該產業全體的世界的概況與各領域將來性的數値資料、概述如下。

第1章 2011 生物科技市場調査評論 – 前言

序文

第2章基因組學、蛋白質組學、上層表觀基因組學研究用樣本調製法（BIO089A）

導論
摘要
概要
生命科學研究工具產業中的樣本調製技法領域的主要趨勢與推進要因
政府方針與財政支援
樣本調製產業的主要企業
樣本調製市場的地理的分布
樣本調製產業中的技術專利

第3章流式細胞儀：產品、技術、世界市場（BIO085A）

導論
摘要
市場推進要因
抑制要因
機會
市場概要
流式細胞儀的進化
流式細胞儀機能分析
分析：主要相關企業、競爭技法、市場
新興市場與技術導入
戰略的提案
專利分析

第4章生物銀行技術以及世界市場（BIO084A）

導論
摘要
概要
現代生物銀行 - 公共領域
生物銀行成本
生物銀行擴大之推進要因
生物銀行擴大障礙
生物銀行的動向與預測
預測今後生物醫學的新發現之生物銀行關懷度

第5章次世代癌症診斷：技術以及世界市場（BIO081A）

導論
摘要
概要
次世代癌症診斷市場性
市場成長推進材料
次世代癌症診斷平台
次世代癌症診斷產品生命週期之現狀
次世代癌症診斷產業

第6章 RNAi藥物輸送：技術以及世界市場（BIO076A）

導論
摘要
RNAi藥物輸送
RNAi送達的應克服的課題
送達技法
摘要

第7章幹細胞腫瘤治療：技術以及世界市場（BIO075A）

導論
摘要
概要
癌症種類
產業定義
產業重要性
腫瘤學之幹細胞研究的進展
今後的展開
對未來的視點

第8章生物晶片全球市場：微陣列與實驗室晶片（BIO049D）

導論
概要
生物晶片種類
報告書範圍
生物晶片市場性
生物晶片市場成長的推進材料
生物晶片產業
摘要

第9章聚合酶連鎖反應（PCR）技術（AVM021G）以及世界市場（BIO087A）

導論
摘要
市場推進要因
市場抑制要因
機會與課題
市場概要
PCR技術進化與其對健康照護產業的影響
傳統型PCR與即時PCR
主要應用領域
PCR定量法
人類基因計畫與PCR
人類微生物群落計畫與PCR
TaqMan探針與分子標識
即時PCR用染色體代替物的有力候補
PCR分析手法的代替案
主要應用領域
PCR與公衆衛生調査
新興市場與技術導入
PCR的將來性
市場動向・重要考察
重要提案・市場戰略
專利分析

圖表一覧

While American Recovery and Reinvestment Act (ARRA) funds helped foster drug research and development, we noticed surprising emphasis on low-possibility-of-success (POS) areas such as antineoplastic and immunomodulating agents, contrasting with smaller sums being sent into higher POS fields, such as acute diseases or dermatology. This somewhat swinging-for-the-fences mentality has a rationale in that if successful these products have much lower post launch competition. But if uncoupled to creative thinking at the R&D stage, one wonders what the ultimate ROI will be for taking this risk, and if patent expiration desperation is fueling this trend. Perhaps significantly, the sports world has names and faces of major league pitchers who have gone ahead with stem cell treatments, with the hopes of resurrecting lucrative careers. Mainstream acceptance of the risk involved in immature therapeutics surely paves the way for more clinical trials and regulatory urgency.

Regarding segmentation, we see many patents and venture capital dollars flowing into synthetic biology applications and " plants engineered to replace oil" efforts, such as algae biofuels and synthetic photosynthesis. The term " Biobrick" has come into common usage and will certainly not fade anytime soon.

This Biotechnology Research Review provides a sampling of the type of quantitative market information, analysis and guidance that has been aiding business decision making since BCC was founded in 1971. It includes highlights from the following reports published in 2011:

Polymerase Chain Reaction (PCR) Technologies and Global Markets Biobanking: Technologies and Global Markets Global Biochip Markets: Microarrays and Lab-on-a-Chip Next-Generation Cancer Diagnostics: Technologies and Global Markets RNAi Drug Delivery: Technologies and Global Markets Stem Cell Therapeutics for Oncology: Technologies and Global Markets Flow Cytometry: Products, Technologies and Global Markets Sample Preparation in Genomics, Proteomics, and Epigenomics: Global Markets

We hope you find this Research Review valuable, and we look forward to serving our customers' biotechnology market research needs.

Chris Spivey

Senior Editor

BCC Research

Chapter- 1: 2011 BIOTECHNOLOGY RESEARCH REVIEW - Complimentary

FOREWORD

Chapter- 2: SAMPLE PREPARATION IN GENOMICS, PROTEOMICS, AND EPIGENOMICS: GLOBAL MARKETS (BIO089A)

INTRODUCTION
SUMMARY
OVERVIEW
MAJOR TRENDS AND DRIVERS IN THE SAMPLE PREP SEGMENT OF LIFE SCIENCE TOOLS INDUSTRY
GOVERNMENT POLICIES AND FUNDING
MAIN MARKET PARTICIPANTS IN THE SAMPLE PREP INDUSTRY
GEOGRAPHIC DISTRIBUTION OF THE SAMPLE PREP MARKET
TECHNOLOGY PATENTS IN THE SAMPLE PREP INDUSTRY

Chapter- 3: FLOW CYTOMETRY: PRODUCTS, TECHNOLOGIES AND GLOBAL MARKETS (BIO085A)

INTRODUCTION
SUMMARY
MARKET DRIVERS
RESTRAINTS
OPPORTUNITIES
MARKET OVERVIEW
EVOLUTION OF FLOW CYTOMETRY
FLOW CYTOMETRY CAPABILITY ANALYSIS
ANALYSES: KEY PLAYERS, COMPETITORS, AND MARKETS
EMERGING ECONOMIES AND TECHNOLOGY ADOPTION
STRATEGIC RECOMMENDATIONS
PATENT ANALYSIS
Figure 9 : PATENT ANALYSIS BY TYPE OF PRODUCT, 2008 - 2010
Table L9 :
Figure 10 : PATENTS BY GEOGRAPHY, 2008 - 2010
Table L10 :

Chapter- 4: BIOBANKING TECHNOLOGIES AND GLOBAL MARKETS (BIO084A)

INTRODUCTION
SUMMARY
OVERVIEW
MODERN BIOBANKS - PUBLIC SECTOR
BIOBANKING COSTS
DRIVERS OF BIOBANKS EXPANSION
BARRIERS TO BIOBANKS EXPANSION
BIOBANKING TRENDS AND FORECAST
FORECAST FOR BIOBANK INVOLVEMENT IN FUTURE BIOMEDICAL DISCOVERIES

Chapter- 5: NEXT-GENERATION CANCER DIAGNOSTICS: TECHNOLOGIES AND GLOBAL MARKETS (BIO081A)14$93

INTRODUCTION
SUMMARY
OVERVIEW
MARKET POTENTIAL OF NEXT-GENERATION CANCER DIAGNOSTICS
FORCES DRIVING MARKET GROWTH
NEXT-GENERATION CANCER DIAGNOSTICS PLATFORMS
NEXT-GENERATION CANCER DIAGNOSTICS PRODUCT LIFE CYCLE STATUS
NEXT-GENERATION CANCER DIAGNOSTICS INDUSTRY
Table 16 : NEXT-GENERATION CANCER DIAGNOSTICS INDUSTRY

Chapter- 6: RNAI DRUG DELIVERY: TECHNOLOGIES AND GLOBAL MARKETS (BIO076A)

INTRODUCTION
SUMMARY
RNAI DRUG DELIVERY
CHALLENGES TO OVERCOME IN DELIVERING RNAI
DELIVERY TECHNIQUES
SUMMARY

Chapter- 7: STEM CELL THERAPEUTICS FOR ONCOLOGY: TECHNOLOGIES AND GLOBAL MARKETS (BIO075A)

INTRODUCTION
SUMMARY
OVERVIEW
TYPES OF CANCER
DEFINITION OF THE INDUSTRY
IMPORTANCE OF THE INDUSTRY
PRODUCT LIFE CYCLES
DEVELOPMENT OF STEM CELLS IN ONCOLOGY
FUTURE DEVELOPMENTS
WITH AN EYE TOWARD THE FUTURE

Chapter- 8: GLOBAL BIOCHIP MARKETS: MICROARRAYS AND LAB-ON-A-CHIP (BIO049D)

INTRODUCTION
OVERVIEW
BIOCHIP TYPES
SCOPE OF REPORT
MARKET POTENTIAL OF BIOCHIPS
DRIVING FORCES FOR GROWTH IN BIOCHIPS MARKETS
THE BIOCHIP INDUSTRY
SUMMARY
Table 44 : GLOBAL VALUE OF BIOCHIP PRODUCTS BY END USE, THROUGH 2016
Figure 15 : GLOBAL VALUE OF BIOCHIP PRODUCTS BY END USE, 2010 - 2016

Chapter- 9: POLYMERASE CHAIN REACTION (PCR) TECHNOLOGIES AND GLOBAL MARKETS (BIO087A)

INTRODUCTION
SUMMARY
MARKET DRIVERS
MARKET RESTRAINTS
OPPORTUNITIES AND CHALLENGES
MARKET OVERVIEW
EVOLUTION OF PCR TECHNOLOGY AND ITS IMPACT ON THE HEALTHCARE INDUSTRY
TRADITIONAL PCR VERSUS REAL-TIME PCR
KEY APPLICATION AREAS
PCR QUANTITATION METHODS
THE HUMAN GENOME PROJECT AND PCR
HUMAN MICROBIOME PROJECT AND PCR
TAQMAN PROBES AND MOLECULAR BEACONS: POTENTIAL ALTERNATIVES TO DYES USED IN REAL-TIME PCR
ALTERNATIVES TO PCR-BASED ANALYTICAL METHODS
KEY APPLICATION AREAS
PCR AND PUBLIC HEALTH SURVEILLANCE
EMERGING ECONOMIES AND TECHNOLOGY ADOPTION
FUTURE OF PCR
MARKET TRENDS/KEY INSIGHTS
KEY RECOMMENDATIONS/MARKET STRATEGIES
PATENT ANALYSIS
Figure 21 : PATENT ANALYSIS BY GEOGRAPHIC REGION, 2008 - 2010
Table L21 :
Figure 22 : PATENT ANALYSIS BY TYPE OF PRODUCT, 2008 - 2010
Table L22 :

List of Tables

Table 1 : GLOBAL MARKET FOR SAMPLE PREPARATION REAGENTS AND PRODUCTS USED IN LIFE SCIENCE RESEARCH BY SEGMENT, THROUGH 2016
Table 2 : GLOBAL MARKET FOR COMMON REAGENTS AND PRODUCTS IN THE LIFE SCIENCE TOOLS INDUSTRY BY SEGMENT, THROUGH 2016
Table 3 : GLOBAL MARKET SHARES OF THE SAMPLE PREP INDUSTRY BY LIFE SCIENCE RESEARCH SEGMENT, 2011
Table 4 : GLOBAL MARKET SHARES OF THE SAMPLE PREP INDUSTRY BY GEOGRAPHIC REGION, 2011
Table 5 : GLOBAL FLOW CYTOMETRY MARKET BY PRODUCT, THROUGH 2015
Table 6 : GLOBAL BIOBANKING REVENUES FORECAST BY SEGMENT, THROUGH 2015
Table 7 : CUMULATIVE NUMBER OF DNA SAMPLES BANKED IN POPULATION-BASED STUDIES*, 1970 - 2009
Table 8 : VALUE OF DNA SAMPLES STORED, THROUGH 2015
Table 9 : NIH-SPONSORED CLINICAL TRIALS CONDUCTING GENE EXPRESSION PROFILING, 2000 - 2008
Table 10 : GLOBAL VALUE OF NEXT-GENERATION CANCER DIAGNOSTICS BY ANALYSIS TYPE, THROUGH 2015
Table 11 : SCOPE OF THIS REPORT
Table 12 : GLOBAL VALUE OF NEXT-GENERATION CANCER DIAGNOSTICS BY INDICATION, THROUGH 2015
Table 13 : FORCES DRIVING CANCER DIAGNOSTICS GROWTH
Table 14 : GLOBAL VALUE OF NEXT-GENERATION CANCER DIAGNOSTICS BY TECHNOLOGY PLATFORM, THROUGH 2015
Table 15 : DIAGNOSTIC PRODUCT LIFE CYCLE STATUS
Table 16 : NEXT-GENERATION CANCER DIAGNOSTICS INDUSTRY
Table 17 : GLOBAL MARKET FOR RNAI DRUG DELIVERY TECHNOLOGIES, THROUGH 2015
Table 18 : ROLE OF DRUG DELIVERY
Table 19 : RNAI DELIVERY APPROACHES
Table 20 : COMPANIES WITH PLASMID RNAI VECTORS
Table 21 : RNAI VIRAL VECTOR DELIVERY METHODS
Table 22 : LENTIVIRAL DELIVERY PRODUCTS AND COMPANIES
Table 23 : THERAPEUTIC STRATEGIES
Table 24 : SIMPLE EXCIPIENTS FOR RNAI DELIVERY
Table 25 : CONJUGATES, PEPTIDES, AND PROTEINS, OTHERS
Table 26 : POLYMER CARRIERS/NANOPARTICLES FOR RNAI DELIVERY
Table 27 : LIPOSOMES/LIPOPLEXES AND RNAI DELIVERY
Table 28 : COMPANIES INVOLVED IN DRUG DELIVERY TECHNOLOGIES FOR SIRNA
Table 29 : GLOBAL MARKET REVENUE FORECAST FOR STEM CELL THERAPEUTIC REGIMENS IN ONCOLOGY, THROUGH 2015
Table 30 : TYPES OF CANCER INCLUDED IN THIS REPORT
Table 31 : COMMON TYPES OF LYMPHOMA
Table 32 : DRUG DEVELOPMENT LIFE CYCLE FOLLOWING DISCOVERY OF NEW DRUG
Table 33 : HISTORICAL PIPELINE OF FDA APPROVED THERAPEUTICS RELATING TO STEM AND PROGENITOR CELLS
Table 34 : KEY PHASE III AND IV STEM CELL CLINICAL TRIALS WITH ESTIMATED COMPLETION DATES BETWEEN 2008 AND 2019
Table 35 : BIOLOGY DOWNSIZING REVOLUTION
Table 36 : COMPARISON OF THE TWO MAJOR BIOCHIP TYPES
Table 37 : BIOCHIP NOMENCLATURE
Table 38 : SCOPE OF REPORT
Table 39 : GLOBAL VALUE OF BIOCHIP PRODUCTS BY TECHNOLOGY, THROUGH 2016
Table 40 : GLOBAL VALUE OF DIAGNOSTIC BIOCHIPS BY FUNCTION, THROUGH 2016
Table 41 : FORCES DRIVING BIOCHIPS GROWTH
Table 42 : 2009 - 2010 STIMULUS FUNDING ALLOCATED TO U.S. SCIENCE SPENDING
Table 43 : COMPARISON OF BIOCHIPS INDUSTRIES
Table 44 : GLOBAL VALUE OF BIOCHIP PRODUCTS BY END USE, THROUGH 2016
Table 45 : GLOBAL PCR TECHNOLOGIES MARKET BY SEGMENT, THROUGH 2015
Table 46 : GLOBAL PCR TECHNOLOGIES MARKET BY GEOGRAPHIC REGION, THROUGH 2015
Table 47 : TRADITIONAL PCR VERSUS REAL-TIME PCR

List of Figures

Figure 1 : GLOBAL MARKET FOR SAMPLE PREPARATION REAGENTS AND PRODUCTS USED IN LIFE SCIENCE RESEARCH BY SEGMENT, 2009 - 2016
Figure 2 : GENOME AND GENE ANALYSIS WORKFLOW
Figure 3 : PROTEIN ANALYSIS WORKFLOW
Figure 4 : GLOBAL FLOW CYTOMETRY MARKET BY PRODUCT, 2008 - 2015
Figure 5 : FLOW CYTOMETRY IMMUNOPHENOTYPING VERSUS CONVENTIONAL MICROSCOPY-BASED IMMUNOPHENOTYPING TECHNIQUES
Figure 6 : DISEASE, DIAGNOSIS, AND MANAGEMENT POTENTIAL OF FCT IMMUNOPHENOTYPING
Figure 7 : GLOBAL FLOW CYTOMETRY MARKET BY PRODUCT
Figure 8 : MARKET PLAYER ANALYSIS - STRATEGIES AND DEVELOPMENTS
Figure 9 : PATENT ANALYSIS BY TYPE OF PRODUCT, 2008 - 2010
Figure 10 : PATENTS BY GEOGRAPHY, 2008 - 2010
Figure 11 : GLOBAL BIOBANKING REVENUES FORECAST BY SEGMENT, 2009 - 2015
Figure 12 : GLOBAL VALUE OF NEXT-GENERATION CANCER DIAGNOSTICS BY ANALYSIS TYPE, 2009 - 2015
Figure 13 : GLOBAL MARKET FOR RNAI DRUG DELIVERY TECHNOLOGIES, 2009 - 2015
Figure 14 : GLOBAL MARKET REVENUE FORECAST FOR STEM CELL THERAPEUTIC REGIMENS IN ONCOLOGY, 2008 - 2015
Figure 15 : GLOBAL VALUE OF BIOCHIP PRODUCTS BY END USE, 2010 - 2016
Figure 16 : GLOBAL PCR TECHNOLOGIES MARKET BY SEGMENT, 2008 - 2015
Figure 17 : IMPACT OF PCR TECHNOLOGY ON THE HEALTHCARE ENVIRONMENT
Figure 18 : KEY APPLICATIONS OF PCR TECHNOLOGY
Figure 19 : DISADVANTAGES OF PCR VS. THE ADVANTAGES OF ALTERNATIVES
Figure 20 : KEY APPLICATIONS OF PCR
Figure 21 : PATENT ANALYSIS BY GEOGRAPHIC REGION, 2008 - 2010
Figure 22 : PATENT ANALYSIS BY TYPE OF PRODUCT, 2008 - 2010

簡介
目錄
相關商品

使用指南產品及服務須知網站導覽

星期一到星期五 / 9:30am - 6:00pm
TEL: 02-2729-4219 (+886-2-2729-4219)
E-mail: tw-info@gii.co.jp

生物科技市場調査評論：2011年

2011 Biotechnology Research Review